---
schema_version: "secwatch.filing_event.v1"
accession: "0001730430-26-000010"
form_type: "8-K"
ticker: "KNSA"
cik: "0001730430"
company_name: "Kiniksa Pharmaceuticals International, plc"
filed_at: "2026-01-14T23:59:59+00:00"
generated_at: "2026-05-16T10:25:24.579102+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kiniksa appoints Ross Moat as COO and Eben Tessari as Chief Strategy Officer

## Summary
- Ross Moat promoted to COO effective Jan 10, 2026; will oversee commercial and functional operations.
- Eben Tessari appointed Chief Strategy Officer effective Jan 10, 2026; adds AI initiatives to strategy and BD.
- No changes to compensation for either executive in connection with the appointments.

## SEC filing metadata
- accession: 0001730430-26-000010
- form_type: 8-K
- ticker: KNSA
- cik: 0001730430
- company_name: Kiniksa Pharmaceuticals International, plc
- filed_at: 2026-01-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1730430/000173043026000010/0001730430-26-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1730430/000173043026000010/knsa-20260110x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001730430-26-000010
- JSON: https://secwatch.observer/filing/0001730430-26-000010.json
- Plain text: https://secwatch.observer/filing/0001730430-26-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.